Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments
Gliomas are one of the most lethal types of cancers accounting for ∼80% of all central nervous system (CNS) primary malignancies. Among gliomas, glioblastomas (GBM) are the most aggressive, characterized by a median patient survival of fewer than 15 months. Recent molecular characterization studies...
Hlavní autoři: | Mahmoud S. Alghamri, Brandon L. McClellan, Carson S. Hartlage, Santiago Haase, Syed Mohd Faisal, Rohit Thalla, Ali Dabaja, Kaushik Banerjee, Stephen V. Carney, Anzar A. Mujeeb, Michael R. Olin, James J. Moon, Anna Schwendeman, Pedro R. Lowenstein, Maria G. Castro |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
Frontiers Media S.A.
2021-05-01
|
Edice: | Frontiers in Pharmacology |
Témata: | |
On-line přístup: | https://www.frontiersin.org/articles/10.3389/fphar.2021.680021/full |
Podobné jednotky
-
Murine brain tumor microenvironment immunophenotyping using mass cytometry
Autor: Brandon L. McClellan, a další
Vydáno: (2022-06-01) -
Impact of epigenetic reprogramming on antitumor immune responses in glioma
Autor: Brandon L. McClellan, a další
Vydáno: (2023-01-01) -
Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies
Autor: Maria B. Garcia-Fabiani, a další
Vydáno: (2021-06-01) -
Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment
Autor: Andrea Franson, a další
Vydáno: (2022-09-01) -
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models
Autor: Santiago Haase, a další
Vydáno: (2022-11-01)